Early brain volume loss on interferon predicts disability progression after 4 years

Early brain volume loss on interferon predicts disability progression after 4 years

Dr. Pérez-Miralles discusses the early implications of brain volume losses…

Expiration Date: 11/12/2016

Max Credits: 0

View Activity

Treatment strategies – determining treatment failure, what to do next

Treatment strategies – determining treatment failure, what to do next

Dr. Miller discusses defining treatment failure discussing subsequent trea…

Expiration Date: 11/12/2016

Max Credits: 0

View Activity

Optimizing Patient Safety and Outcomes by Individualizing Therapy

Optimizing Patient Safety and Outcomes by Individualizing Therapy

Since the approval of interferon beta-1b, multiple additional therapies ha…

Expiration Date: 11/12/2016

Max Credits: 0

View Activity

Making Informed Decisions When Screening and Monitoring

Making Informed Decisions When Screening and Monitoring

Since the approval of interferon beta-1b, multiple additional therapies ha…

Expiration Date: 11/12/2016

Max Credits: 0

View Activity

No evident disease activity in relapsing MS patients treated with interferon β-1a SC vs. interferon β-1a IM: subgroup analyses of the EVIDENCE study

No evident disease activity in relapsing MS patients treated with interferon β-1a SC vs. interferon β-1a IM: subgroup analyses of the EVIDENCE study

Dr. Coyle discusses the most current research on the effect of interferon …

Expiration Date: 11/12/2016

Max Credits: 0

View Activity

Long-term effects of fampridine on walking ability in patients with multiple sclerosis: a phase II, open-label, uncontrolled, monocenter study

Long-term effects of fampridine on walking ability in patients with multiple sclerosis: a phase II, open-label, uncontrolled, monocenter study

Dr. Filli discusses the most current research on the effect of fampridine …

Expiration Date: 11/12/2016

Max Credits: 0

View Activity

MicroRNA miR-21 is induced by interferon-beta and inhibits IL-12 expression: a novel immunomodulatory mechanism in multiple sclerosis

MicroRNA miR-21 is induced by interferon-beta and inhibits IL-12 expression: a novel immunomodulatory mechanism in multiple sclerosis

Dr. Balashov discusses the effect of interferon beta on interleukin-12 in …

Expiration Date: 11/12/2016

Max Credits: 0

View Activity

MS Forum

MS Forum

Multiple sclerosis (MS) is a chronic, immune-mediated inflammatory disease…

Expiration Date: 12/18/2015

Max Credits: 0

View Activity

Long-term treatment of intrathecal baclofen in multiple sclerosis: frequency and severity of withdrawal syndrome

Long-term treatment of intrathecal baclofen in multiple sclerosis: frequency and severity of withdrawal syndrome

Dr. Stetkarova discusses the use of intrathecal baclofen to treat MS patie…

Expiration Date: 11/12/2016

Max Credits: 0

View Activity

A novel MIF inhibitor as therapy for multiple sclerosis and stroke

A novel MIF inhibitor as therapy for multiple sclerosis and stroke

Dr. Vandenbark discusses the research on a strategy to treat all patients …

Expiration Date: 12/17/2015

Max Credits: 0

View Activity